In the univariate analysis, patients’ clinical and biochemical factors, viral markers, fibrosis stage of NTs, and grade of HCC were not associated with AKR1B10 expression in NTs, and hepatic steatosis was the only parameter significantly associated with AKR1B10 expression. Here, AKR1B10 is linked to hepatocellular carcinoma.